Valcarce Lopez, Maria Carmen,Orlandi, Cesare,Clark, David J.,Grimes, Imogene M.,Kostura, Matthew J.
申请号：
NZ73952113
公开号：
NZ739521A
申请日:
2013.10.02
申请国别(地区):
NZ
年份:
2019
代理人:
摘要：
The present invention relates to methods of treatment using [3-(4-{ 2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl} -phenoxy)-propyl]-diethyl amine (”COMPOUND I”) or a pharmaceutically acceptable salt thereof. In various embodiments, the methods of treatment include treatment of mild-to-moderate dementia of Alzheimer’s type, diabetes, insomnia, and other indications. The present invention also relates to pharmaceutical compositions comprising COMPOUND I or a pharmaceutically acceptable salt thereof.
